Manufacturing News and Research

RSS
Akela reports total consolidated revenues of $4.2 million for three months ended March 31, 2011

Akela reports total consolidated revenues of $4.2 million for three months ended March 31, 2011

Morimatsu acquires Pharmadule

Morimatsu acquires Pharmadule

Accuray acquires TomoTherapy

Accuray acquires TomoTherapy

EarlySense's new WiFi patient monitoring system receives FDA clearance and CE approval

EarlySense's new WiFi patient monitoring system receives FDA clearance and CE approval

Circassia announces ToleroMune vaccine phase II trial results against cat allergy

Circassia announces ToleroMune vaccine phase II trial results against cat allergy

Mystic's key manufacturing technology for drug, biologic delivery systems receives U.S. patent

Mystic's key manufacturing technology for drug, biologic delivery systems receives U.S. patent

Hanwha, Merck partner to develop and commercialize HD203

Hanwha, Merck partner to develop and commercialize HD203

HHS adds eight substances to 12th Report on Carcinogens

HHS adds eight substances to 12th Report on Carcinogens

NIOSH grants Noveko N95 certification for RD5-V respirator

NIOSH grants Noveko N95 certification for RD5-V respirator

Patheon second quarter revenues decrease 3.1% to $170.0 million

Patheon second quarter revenues decrease 3.1% to $170.0 million

Chinese medical devices market to achieve revenues of $30.6B by 2017

Chinese medical devices market to achieve revenues of $30.6B by 2017

Masimo receives GOLD 2011 Medical Design Excellence Award for Pronto-7 noninvasive hemoglobin

Masimo receives GOLD 2011 Medical Design Excellence Award for Pronto-7 noninvasive hemoglobin

Accuray receives shareholders approval to acquire TomoTherapy

Accuray receives shareholders approval to acquire TomoTherapy

Respira introduces breakthrough Dry Powder Inhaler

Respira introduces breakthrough Dry Powder Inhaler

University of Mississippi grants ChromaDex global rights to pterostilbene

University of Mississippi grants ChromaDex global rights to pterostilbene

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

UAB acquires first cell-processing workstation from SANYO

UAB acquires first cell-processing workstation from SANYO

New grade of polycarbonate meets growing trend for thinner walls in medical devices

New grade of polycarbonate meets growing trend for thinner walls in medical devices

UAB first in U.S. with cell-processing workstation

UAB first in U.S. with cell-processing workstation

Conference panel examines manufacturing of nutrition-rich foods

Conference panel examines manufacturing of nutrition-rich foods

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.